About Synergy CHC
Synergy CHC is a publicly listed company based in Westbrook (United States) founded in 2012. Health supplements and personal care products are manufactured and marketed. The company has 21 employees. Synergy CHC has completed 1 acquisition, including UrgentRX. Synergy CHC offers products and services including FOCUS FACTOR, FLAT TUMMY CO, and HAND MD. Its focus areas include Life Sciences, Nutraceuticals Tech, Supplements and Multicategory. Its legal entity is SYNERGY CHC CORP. Its competitors include Carson Life, Mead johnson and Balchem; 1 of its 3 listed competitors has raised funding.
Company details
Synergy CHC was established in 2012 in Westbrook, United States, within the health and personal care sector. A portfolio of six products is maintained, including brain health supplements, detox teas, and pain relief options. Manufacturing and marketing activities are conducted, with distribution handled online and via retailer partnerships. Expansion of the product line is planned for the future.
- Headquarters Westbrook, United States
- Employees 21
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website synergychc.com
- Social LinkedIn X Facebook Instagram
- Legal Name Synergy Chc Corp.
- Annual Revenue$34.83 M (USD)-18.57as on Dec 31, 2024
- Net Profit$2.12 M (USD)-66.48as on Dec 31, 2024
- EBITDA$5.55 M (USD)-58.12as on Dec 31, 2024
- Latest Funding Round$10M (USD), Debt – Conventional
Aug 2017
- Investors
- Employee Count21
- Investments & Acquisitions
Products & Services of Synergy CHC
Synergy CHC offers a comprehensive portfolio of products and services, including FOCUS FACTOR, FLAT TUMMY CO, and HAND MD.
Brain health supplement brand for cognitive support
Lifestyle brand for weight management and health
Hand care products for clean and healthy skin
Funding Insights of Synergy CHC
- Total Rounds 1
- Last Round Debt – Conventional — $10M
- First Round $10M
(Aug 2017)
- Investors Count 1
All 1 funding rounds of Synergy CHC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | $10M | Debt – Conventional | – | – |
1 investors in total: 1 institutional.
Investors in Synergy CHC
Synergy CHC has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Knight Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Prescription pharmaceuticals are acquired, licensed, and commercialized by the company. | 2014 | gud-knight.com | Westmount, Canada |
Investor details for Synergy CHC
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Synergy CHC
13 people are tracked at Synergy CHC (10 in leadership, 3 in board & advisors); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
Jack Ross | Chairman & CEO | Leadership |
Jaime Fickett | Chief Financial Officer | Leadership |
Alfred Baumeler | President | Leadership |
Larry Pairo | VP, Operations & Supply Chain | Leadership |
Brendan Horning | Chief Financial Officer | Leadership |
Shelby Reilly | Director Of Brand Strategy | Leadership |
Erik Shields | Vice President Of Beverage | Leadership |
Frederic Paul Carpenter | Creative Director | Leadership |
Kelly Dressler | Vice President Regulatory Affairs | Leadership |
Bob Anderson | National Director Of DSD | Leadership |
Stephen J. Fryer | Board Member | Board & advisors |
Nitin Kaushal | Board Member | Board & advisors |
Paul Sorelle | Board Member | Board & advisors |
Complete people profiles for Synergy CHC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Synergy CHC
Synergy CHC is a publicly listed company on the NASDAQ with ticker symbol SNYR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Oct 2024
- Listed onNASDAQ: SNYR
- Listed entitySynergy CHC Corp.
- Exchange sectorHealth technology
- ISINUS87165D2080
- Share price$0.39 (-1.29% on the day) · 2026-05-11
- Market capitalisation$5.8M
- Price to earnings6.3
- EPS (diluted, trailing year)$-1.03
- Volume (last session)3,051,761
- Analyst consensusStrong buy
Financials of Synergy CHC
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2024 | $34.8M | $2.1M | $5.5M |
| 2023 | $42.8M | $6.3M | $13.2M |
| 2022 | $38.4M | -$32.6M | -$24.6M |
| 2020 | $40.2M | $1.4M | $3.2M |
| 2019 | $29.4M | -$9.2M | $3.0M |
Detailed financial statements for Synergy CHC
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synergy CHC
Synergy CHC has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include UrgentRX.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Over-the-counter medications are delivered in portable powdered packets. | urgentrx.com | Denver, United States | 2010 | Nov 2015 | •••• |
Complete acquisition details for Synergy CHC
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Synergy CHC
4 dated milestones of Synergy CHC across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Synergy CHC is founded.
- Acquisition Acquires UrgentRX.
- Funding First funding round of $10.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Synergy CHC
Synergy CHC has 3 listed competitors in our database, 1 of them funded. They include Carson Life, Mead johnson and Balchem.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| carsonlife.com | 2014 | Miami, United States | $5.44M | Natural health and beauty products are manufactured in various categories. | ||
| meadjohnson.com | 1900 | Chicago, United States | 570 | Infant nutrition products are manufactured and marketed by Mead Johnson. | ||
| balchem.com | 1967 | New Hampton, United States | 2,293 | Nutraceutical ingredients are manufactured for human and animal nutrition products. |
Detailed competitors of Synergy CHC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synergy CHC
The website of Synergy CHC (synergychc.com) receives about 1.3K visits a month.
- Monthly visits1.3K
▼ 18.6% vs previous month
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Synergy CHC (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Synergy Chc
Complete news archive for Synergy CHC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synergy CHC
Synergy CHC was founded in 2012 and raised its 1st funding round 5 years after it was founded.
Synergy CHC is headquartered in Westbrook, United States. It is registered at Westbrook, Maine, United States.
Synergy CHC has 21 employees.
Annual revenue of Synergy CHC is $34.83M as on Dec 31, 2024.
Synergy CHC was established in 2012 in Westbrook, United States, within the health and personal care sector. A portfolio of six products is maintained, including brain health supplements, detox teas, and pain relief options. Manufacturing and marketing activities are conducted, with distribution handled online and via retailer partnerships. Expansion of the product line is planned for the future.
Synergy CHC's top competitors include Mead johnson, Balchem and Carson Life.
Synergy CHC offers FOCUS FACTOR, FLAT TUMMY CO, and HAND MD.
Yes, Synergy CHC is publicly traded on NASDAQ under the ticker symbol SNYR.
Synergy CHC has made 1 acquisition, including UrgentRX.
Synergy CHC has 1 investor. Key investors include Knight Therapeutics.
Synergy CHC operates through Synergy Chc Corp..